183 results
Page 2 of 10
20-F/A
EX-12.2
xknbf 0m0
9 Sep 22
Annual report (foreign) (amended)
4:15pm
6-K
EX-99
hklrf7
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
mhqmoeuqhtr k3
16 Jun 22
BioLineRx Announces Appointment of Commercial Strategy
7:05am
6-K
EX-99
sskrhs
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-99
1mqmibsjko opit4
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
EX-10.1
2zk6obn
3 Sep 21
Current report (foreign)
4:30pm
424B5
t6pvwtpo1x2s euh
3 Sep 21
Prospectus supplement for primary offering
4:29pm
POS AM
kgzbgwemccnm
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99
iw1 qha50ajfi
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
jcvygpxse9cu8u3
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
n36 09p1ic
19 Jan 21
Prospectus supplement for primary offering
5:00pm